NRCT-101SR
- Generic Name
- NRCT-101SR
Study to Evaluate NRCT-101SR in Pediatric Subjects with ADHD
Phase 2
Recruiting
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT06215144
- Locations
- 🇺🇸
Advanced Research Center, Inc, Anaheim, California, United States
🇺🇸Accel Research Sites - Lakeland Clinical Research Unit, Lakeland, Florida, United States
🇺🇸Accel Research Sites Network - Maitland, Maitland, Florida, United States
Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 223
- Registration Number
- NCT05683249
- Locations
- 🇺🇸
Velocity Clinical Research - Meridian, Meridian, Idaho, United States
🇺🇸Center for Psychiatry and Behavioral Medicine, Las Vegas, Nevada, United States
🇺🇸Accel Research Sites, Maitland, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath